The U.S. government said on Monday it would provide about $11 million to support the packaging of Bavarian Nordic’s BAVA.CO Jynneos monkeypox vaccine at a U.S.-based manufacturer’s facility.

The Danish company, which is the maker of the only approved monkeypox vaccine, had earlier this month signed up Michigan-based Grand River Aseptic Manufacturing to package the two-dose shot.

The production is expected to begin later this year, the U.S. Department of Health and Human Services said, adding that the funding will help the manufacturer recruit more staff and buy additional equipment.

Globally, the number of confirmed monkeypox cases have crossed 47,600 with over 17,000 cases reported in the United States so far.

The Jynneos vaccine is in short supply and U.S. regulators have authorized a method of administration that allows providers to get five doses instead of one from a single vial to expand access.

The United States initially ordered 3 million doses and in July sought another 2.5 million doses. Bavarian Nordic said the additional doses would be packaged at the U.S. facility.

The delivery of the total 5.5 million doses is spread across this year and the next.

More than 207,000 doses of Jynneos vaccine have been given in the country as of Aug. 23, but very few people have received the second shot needed for full protection, U.S. Centers for Disease Control and Prevention Director Rochelle Walensky said last week.
…

your ads here!

Engineers for the U.S. space agency NASA were troubleshooting several issues early Monday ahead of the planned launch of a new rocket and crew capsule designed to send humans back to the moon. 

NASA teams dealt with delays due to a thunderstorm that passed over the launch site in the southeastern state of Florida as well as a leak discovered during fueling operations. 

NASA’s assistant launch director, Jeremy Graeber, said Monday’s scheduled launch could still go forward. If it does not, another try could happen on Friday. 

The test involves the Space Launch System rocket, the most powerful in NASA’s history, which will propel the Orion capsule without any people on board for this flight. Orion is due to go around the moon and return to Earth, with the entire journey taking about six weeks.    

If successful, NASA plans to fly astronauts around the moon in 2024 and potentially put them on the lunar surface as early as 2025.     

The launch is part of NASA’s Artemis program, which aims to have humans walk on the moon for the first time since 1972, including the first woman and person of color to do so.    

NASA is also planning a moon base as part of Artemis, and says it will use what it learns to inform efforts to send the first astronauts to Mars.    

Some information for this story came from The Associated Press, Agence France-Presse and Reuters  
…

your ads here!

The world’s population is surging, and with it, the global demand for poultry and seafood. Some companies are hoping to offer lab-grown meat-based products with the same taste and texture as animal flesh. VOA’s Julie Taboh has more from Washington.
…

your ads here!

Years late and billions over budget, NASA’s new moon rocket makes its debut next week in a high-stakes test flight before astronauts get on top.

The 98-meter (322-foot) rocket will attempt to send an empty crew capsule into a far-flung lunar orbit, 50 years after NASA’s famed Apollo moonshots.

If all goes well, astronauts could strap in as soon as 2024 for a lap around the moon, with NASA aiming to land two people on the lunar surface by the end of 2025.

Liftoff is set for Monday morning from NASA’s Kennedy Space Center.

The six-week test flight is risky and could be cut short if something fails, NASA officials warn.

“We’re going to stress it and test it. We’re going make it do things that we would never do with a crew on it in order to try to make it as safe as possible,” NASA Administrator Bill Nelson told The Associated Press on Wednesday.

The retired founder of George Washington University’s space policy institute said a lot is riding on this trial run. Spiraling costs and long gaps between missions will make for a tough comeback if things go south, he noted.

“It is supposed to be the first step in a sustained program of human exploration of the moon, Mars, and beyond,” said John Logsdon. “Will the United States have the will to push forward in the face of a major malfunction?”

The price tag for this single mission: more than $4 billion. Add everything up since the program’s inception a decade ago until a 2025 lunar landing, and there’s even more sticker shock: $93 billion.

Here’s a rundown of the first flight of the Artemis program, named after Apollo’s mythological twin sister.

Rocket power

The new rocket is shorter and slimmer than the Saturn V rockets that hurled 24 Apollo astronauts to the moon a half-century ago. But it’s mightier, packing 8.8 million pounds (4 million kilograms) of thrust. It’s called the Space Launch System rocket, SLS for short, but a less clunky name is under discussion, according to Nelson. Unlike the streamlined Saturn V, the new rocket has a pair of strap-on boosters refashioned from NASA’s space shuttles. The boosters will peel away after two minutes, just like the shuttle boosters did, but won’t be fished from the Atlantic for reuse. The core stage will keep firing before separating and crashing into the Pacific in pieces. Two hours after liftoff, an upper stage will send the capsule, Orion, racing toward the moon.

Moonship

NASA’s high-tech, automated Orion capsule is named after the constellation, among the night sky’s brightest. At 3 meters (11 feet) tall, it’s roomier than Apollo’s capsule, seating four astronauts instead of three. For this test flight, a full-size dummy in an orange flight suit will occupy the commander’s seat, rigged with vibration and acceleration sensors. Two other mannequins made of material simulating human tissue — heads and female torsos, but no limbs — will measure cosmic radiation, one of the biggest risks of spaceflight. One torso is testing a protective vest from Israel. Unlike the rocket, Orion has launched before, making two laps around Earth in 2014. This time, the European Space Agency’s service module will be attached for propulsion and solar power via four wings.

Flight plan

Orion’s flight is supposed to last six weeks from its Florida liftoff to Pacific splashdown, twice as long as astronaut trips in order to tax the systems. It will take nearly a week to reach the moon, 386,000 kilometers (240,000 miles) away. After whipping closely around the moon, the capsule will enter a distant orbit with a far point of 61,000 kilometers (38,000 miles). That will put Orion 450,000 kilometers (280,000 miles) from Earth, farther than Apollo. The big test comes at mission’s end, as Orion hits the atmosphere at 40,000 kph (25,000 mph) on its way to a splashdown in the Pacific. The heat shield uses the same material as the Apollo capsules to withstand reentry temperatures of  2,750 degrees Celsius (5,000 degrees Fahrenheit). But the advanced design anticipates the faster, hotter returns by future Mars crews.

Hitchhikers

Besides three test dummies, the flight has a slew of stowaways for deep space research. Ten shoebox-size satellites will pop off once Orion is hurtling toward the moon. The problem is these so-called CubeSats were installed in the rocket a year ago, and the batteries for half of them couldn’t be recharged as the launch kept getting delayed. NASA expects some to fail, given the low-cost, high-risk nature of these mini satellites. The radiation-measuring CubeSats should be OK. Also, in the clear: a solar sail demo targeting an asteroid. In a back-to-the-future salute, Orion will carry a few slivers of moon rocks collected by Apollo 11’s Neil Armstrong and Buzz Aldrin in 1969, and a bolt from one of their rocket engines, salvaged from the sea a decade ago. Aldrin isn’t attending the launch, according to NASA, but three of his former colleagues will be there: Apollo 7’s Walter Cunningham, Apollo 10’s Tom Stafford and Apollo 17’s Harrison Schmitt, the next-to-last man to walk on the moon.

Apollo vs. Artemis

More than 50 years later, Apollo still stands as NASA’s greatest achievement. Using 1960s technology, NASA took just eight years to go from launching its first astronaut, Alan Shepard, and landing Armstrong and Aldrin on the moon. By contrast, Artemis already has dragged on for more than a decade, despite building on the short-lived moon exploration program Constellation. Twelve Apollo astronauts walked on the moon from 1969 through 1972, staying no longer than three days at a time. For Artemis, NASA will be drawing from a diverse astronaut pool currently numbering 42 and is extending the time crews will spend on the moon to at least a week. The goal is to create a long-term lunar presence that will grease the skids for sending people to Mars. NASA’s Nelson, promises to announce the first Artemis moon crews once Orion is back on Earth.

What’s next

There’s a lot more to be done before astronauts step on the moon again. A second test flight will send four astronauts around the moon and back, perhaps as early as 2024. A year or so later, NASA aims to send another four up, with two of them touching down at the lunar south pole. Orion doesn’t come with its own lunar lander like the Apollo spacecraft did, so NASA has hired Elon Musk’s SpaceX to provide its Starship spacecraft for the first Artemis moon landing. Two other private companies are developing moonwalking suits. The sci-fi-looking Starship would link up with Orion at the moon and take a pair of astronauts to the surface and back to the capsule for the ride home. So far, Starship has only soared 10 kilometers (six miles). Musk wants to launch Starship around Earth on SpaceX’s Super Heavy Booster before attempting a moon landing without a crew. One hitch: Starship will need a fill-up at an Earth-orbiting fuel depot, before heading to the moon.
…

your ads here!

Citing unparalleled attacks on health care facilities, the World Health Organization said this week it is working to reconstruct Ukraine’s health system. The system has suffered extensive damage since Russia invaded the country six months ago.

Over the past six months, the U.N. health agency says it has verified 173 attacks on medical facilities, which have resulted in nearly 100 deaths and 134 injuries.

WHO Ukraine representative Jarno Habicht told reporters this week that deaths and injuries continue to rise and will continue to do so until Russia ends the war.

“While these attacks are not only the violation of international law, they also are a barrier for many who need care as we are going through the war,” he said. “So, it is not only the supplies and others that we need to support, we need to ensure also that the services are available. But also, the health care workers are under immediate risk as we go through these times.”

The United Nations says the war has killed more than 5,500 civilians and injured nearly 8,000, including almost 1,000 children. UNICEF says about five children on average are killed or injured every day. The children’s agency says this is due to the indiscriminate use of weapons, often in heavily populated areas.

Speaking via videolink from an air raid shelter in Dnipro, in central Ukraine, Habicht said many people are on the move and many are suffering and need care.

He said the WHO is accelerating efforts to reach out and provide humanitarian assistance to millions of people across the country.  At the same time, he said the WHO is working on rebuilding Ukraine’s shattered health system in coordination with national and local authorities.

“Reconstruction of the health system has to be part of the recovery of the whole country across all the sectors,” he said. “And that is why we are currently concentrating both on the humanitarian response, as well looking to the recovery as we have seen in the health sector and other sectors.” 

To date, the WHO has delivered more than 1,300 metric tons of medical supplies in Ukraine, including medicines for diabetes, cardiovascular disorders and other noncommunicable diseases.

Habicht said support also is being provided for mental health, trauma, and emergencies. He also said COVID-19 vaccines have been delivered to Ukraine in recent weeks in light of the increasing mortality rate from the virus across the country.
…

your ads here!

Canada’s decision to legalize recreational marijuana in October 2018 was greeted by advocates and critics with predictions of dramatic benefits or dire consequences. Almost four years later, questions about the impact of the move elicit mainly shrugs.

“Maybe I am the wrong demographic, but I have not noticed any serious problems arising from legalization,” said one senior veteran of the Canadian legal system, who declined to be identified because of his role in administering the law.

“I think it probably has reduced policing costs and court time arising from simple possession offences (as opposed to trafficking),” the legal veteran added in an email to VOA. “No evidence of lawyers or bankers or Bay Street types going wild. Maybe alcohol is still the drug of choice.

“You do get the occasional whiff of weed walking down Bay Street,” Toronto’s financial industry core, the legal practitioner added, “and there has been an unbelievable (and maybe unsustainable) proliferation of marijuana stores.”

Anecdotal evidence of that sort is the best measure so far of legalization’s impact in just the second country to legalize recreational use of the drug, given a dearth of hard data on the effect on traffic accidents, drug overdoses, mental health outcomes or petty crime.

“Unfortunately, there hasn’t been concrete data I’ve seen that allows someone to comment on all of those goals and how Canada is doing in regards to them,” said Jonathan Wilson, chief executive officer of Crystal Cure Inc., a craft producer of cannabis in the eastern province of New Brunswick.

The 2018 legislation legalizing marijuana called for a thorough assessment of the impact after three years, but the government still has not begun that process, a source of frustration for some in the legal marijuana industry who are seeking reforms that would give them a boost against their illicit competitors.

In fact, the illicit trade has proven surprisingly durable despite the ready availability of legal marijuana at government-licensed outlets. One reason for that may be user complaints about the taste and quality of the legally approved products.

Jon Cappetta, vice president of content with U.S.-based High Times Magazine, said in an interview that the Canadian industry has a reputation for low-quality mass-produced marijuana, which he dismissed as “Walmart weed.”

“That’s not to say there’s not great product up there,” Cappetta said. “But it’s mainly on the traditional market, not the legal one.”

Wilson said it was not until the end of last year that legal marijuana sales surpassed illicit sales, according to estimates by the Ontario Cannabis Store, the only legal online retailer of recreational marijuana in Canada’s most populous province.

“We don’t know exactly how this is measured, but regardless of the lack of empirical data on this, it is very apparent in many parts of the country that the illicit market is very much alive and well.”

That has cut into early projections for a big boost to the economy through direct and indirect taxes, though the benefits are not insignificant.

According to a report prepared by the Deloitte consultancy firm and reported by MJBiz Daily in February, the industry had contributed $34.2 billion through the end of 2021 to a national GDP that totaled almost $2 trillion last year.

On the other hand, fears of an epidemic of underage marijuana use have also not borne out. “Regarding prevalence, there appears to have been no marked increase in cannabis use by youth in Canada yet,” reported the Journal of the Canadian Academy of Child and Adolescent Psychiatry in 2021.

The report went on to say, “In the lead up to legalization, professional associations including the Canadian Psychiatric Association, the Canadian Medical Association, and the Canadian Pediatric Society suggested that legalization posed a threat to public health, advocated for the legal age for cannabis use to be set at a minimum age of 21 or 25, or that Canada should not legalize at all because it would place youth at greater risk of harm. With such categorical fears now shown to be largely unfounded, this should provide the basis to move forward on more nuanced grounds.”

The Canadian Medical Association, for its part, continues to advise caution. “Today, we continue to advocate for a public health approach to cannabis with three primary aims: prevent problematic drug use; make assessment, counseling and treatment services more available; and improve safety for those who use through harm reduction programs and awareness,” it says on its website.

The limited data that exists provides a mixed picture of the impact on road safety. The federal agency Public Safety Canada reported last year that “while police-reported data tends to indicate a significant decline in overall trends in impaired driving incidents over the past ten years, the proportion of [drug-impaired driving] incidents reported by police has significantly increased from about 2% of the total in 2009, to approximately 9% in 2020.”

On the other hand, the report said, its survey data “tends to indicate that public education and awareness campaigns … appear to have effectively changed Canadians’ perceptions around driving after cannabis use, with an increasing number of respondents agreeing that cannabis use impairs driving abilities. Furthermore, the proportion of Canadians reporting driving after cannabis use has continued to decline in 2020.”

One of the more challenging issues for the nation’s police forces has been whether to permit their own officers to indulge while off duty. Many forces, including the storied Royal Canadian Mounted Police, banned its use altogether while others, particularly in liberal-leaning cities like Vancouver, authorized its off-duty use as long as the officers showed up to work fit for duty.

John Orr is president of the police association in Calgary, Alberta, where officers in February won the right to use cannabis while off duty. Such use “is not unheard of and in Vancouver, it’s been my understanding there’s been no issues at all,” Orr told the Calgary Herald newspaper at the time.

The same article quoted Andrea Urquhart, the executive director of human resources with the Calgary Police Service, saying, “There’s no evidence this particular change would be detrimental to our fundamental goal to serve and protect.”

Jo-Ann Roberts, a former interim leader of the Green Party of Canada, sees what data is available as a vindication of the party’s early advocacy for legalization.

“We believed it would not result in the lawlessness many predicted. In fact, we believed it would reduce policing costs, take pressure off the courts and reduce the influence of organized crime,” she told VOA. “I think provinces and producers are still working out the details of delivering the product, but overall the transition from illegal to legal has gone smoothly.”

Brennan Sisk, the former cannabis coordinator for an NGO based in Fredericton, New Brunswick, argued that legalization has opened the door to peer-reviewed research on the health impact of marijuana and the development of industrial uses.

But, he said, the government has not embraced cannabis as a legal part of everyday culture and continues to approach it “strictly from a harm reduction mechanism.”

“I think Canada has developed a good set of best practices and is ahead of the curve when it comes to identifying practical and productive changes to restrictions,” Sisk said.

“Those working in the Canadian system are well positioned to advise new jurisdictions on how to roll out a legal plan while benefiting from an economic development perspective.”
…

your ads here!

As fall draws near in the U.S, Monarch butterflies in the eastern part of the country are primed for their winter sojourn to Mexico. Conservationists worry that the Monarchs are in peril from climate change and farming, but the science isn’t settled. VOA’s Veronica Balderas Iglesias looks at the complexities of counting and protecting Monarch butterflies.
…

your ads here!

U.N. member states ended two weeks of negotiations Friday without a treaty to protect biodiversity in the high seas, an agreement that would have addressed growing environmental and economic challenges.

After 15 years, including four prior formal sessions, negotiators have yet to reach a legally binding text to address the multitude of issues facing international waters — a zone that encompasses almost half the planet.

“Although we did make excellent progress, we still do need a little bit more time to progress towards the finish line,” said conference chair Rena Lee.

It will now be up to the U.N. General Assembly to resume the fifth session at a date still to be determined.

Many had hoped the session, which began on Aug. 15 at the United Nations headquarters in New York, would be the last and yield a final text on “the conservation and sustainable use of marine biodiversity beyond national jurisdiction,” or BBNJ for short.

“While it’s disappointing that the treaty wasn’t finalized during the past two weeks of negotiations, we remain encouraged by the progress that was made,” said Liz Karan with the NGO Pew Charitable Trusts, calling for a new session by the end of the year.

One of the most sensitive issues in the text revolved around the sharing of possible profits from the development of genetic resources in international waters, where pharmaceutical, chemical and cosmetic companies hope to find miracle drugs, products or cures.

Such costly research at sea is largely the prerogative of rich nations, but developing countries do not want to be left out of potential windfall profits drawn from marine resources that belong to no one.

‘Missed opportunity’

Similar issues of equity arise in other international negotiations, such as on climate change, in which developing nations that feel outsized harm from global warming have tried in vain to get wealthier countries to help pay to offset those impacts.

The high seas begin at the border of a nation’s exclusive economic zone (EEZ) — which by international law reaches no more than 200 nautical miles (370 kilometers) from its coast — and are under no state’s jurisdiction.

Some 60% of the world’s oceans fall under this category.

And while healthy marine ecosystems are crucial to the future of humanity, particularly to limit global warming, only 1% of international waters are protected.

One of the key pillars of an eventual BBNJ treaty is to allow the creation of marine protected areas, which many nations hope will cover 30% of the Earth’s ocean by 2030.

“Without establishing protections in this vast area, we will not be able to meet our ambitious and necessary 30 by 30 goal,” U.S. State Department official Maxine Burkett said at an earlier press conference.

But delegations still disagree on the process for creating these protected areas, as well as on how to implement a requirement for environmental impact assessments before new activity on the high seas.

“What a missed opportunity…” tweeted Klaudija Cremers, a researcher at the IDDRI think tank, which, like multiple other NGOs, has a seat with observer status at the negotiations.
…

your ads here!

The head of the U.S. Centers for Disease Control and Prevention (CDC) said Friday that very few people in the United States have received a full series of monkeypox vaccinations.

CDC Director Rochelle Walensky said the large majority of Americans who received a first dose of the vaccine have yet to get their second dose, despite being eligible.

She told a White House briefing Friday that nearly 97% of the inoculations administered so far have been first doses.

Walensky said that while the vaccine was initially hard to get, supplies have now increased.

Earlier this month, the U.S. Food and Drug Administration (FDA) allowed for the vaccine to be injected in smaller doses to help stretch supplies.

The Biden administration says it has shipped enough vaccines to jurisdictions around the United States for at least 1.6 million doses.

CDC data show that about 10% of monkeypox vaccine doses have been given to Black people despite the fact that they account for one-third of U.S. cases.

The rate was compiled from 17 U.S. states and two cities.

Walensky said the CDC has taken measures to make the vaccine more accessible to Blacks and other minorities. She said vaccines and educational materials will be available at two upcoming events — Atlanta’s Black Pride festival and New Orleans’ Southern Decadence.

Walensky said the agency is starting to roll out such pilot projects and that “they are working.”

Most cases of monkeypox in the United States have occurred in gay men, but health officials have stressed that anyone can catch the virus.

More than 16,000 people have been infected with the virus in the United States, more than in any other country.

Walensky noted that the spread of the virus is falling in several major U.S. cities.

“We’re watching this with cautious optimism, and really hopeful that many of our harm-reduction messages and our vaccines are getting out there and working,” she said.

Across the United States, cases of monkeypox are still increasing. However, officials say the pace of the outbreak appears to be slowing.

On Thursday, the World Health Organization said global cases of monkeypox dropped 21% in the past week.

The WHO said cases appeared to be slowing in Europe but warned that infections in the Americas were on “a continuing steep rise.”

“In Latin America in particular, insufficient awareness or public health measures are combining with a lack of access to vaccines to fan the flames of the outbreak,” WHO Director-General Tedros Adhanom Ghebreyesus told a press briefing.

Monkeypox has been endemic in parts of Africa for decades, but since May, cases have been reported around the world.

The virus is typically spread by skin-to-skin contact with an infected person’s lesions. It can also be spread through contact with an infected person’s clothing or sheets.

Some information for this report came from The Associated Press and Reuters.
…

your ads here!

The first crewed flight of Boeing’s space capsule Starliner is scheduled for February 2023, the company and NASA announced Thursday, as the United States seeks to secure a second way for its astronauts to reach the International Space Station.

Since 2020, American astronauts have traveled to the ISS aboard SpaceX’s vessels, but the U.S. space agency wants to widen its options.

After a series of hiccups in its space program that led to serious delays, including a 2019 flight that did not reach the ISS, Boeing finally managed to send the gumdrop-shaped capsule to the station in May — without a crew.

This time, the aerospace giant will send up the Starliner with humans aboard to earn NASA’s green light to begin regular missions at an expected pace of one per year.

“Currently, we’re targeting a launch date as early as February of 2023,” Steve Stich, manager of NASA’s Commercial Crew Program, told reporters.

“We’re in good shape to execute these plans to be ready for that flight in February,” added Mark Nappi, Starliner program manager at Boeing.

The test flight — aptly named CFT, or Crew Flight Test — will carry U.S. astronauts Barry Wilmore and Sunita Williams.

They are expected to be docked for eight days at the ISS, where they will conduct a series of experiments, said ISS program manager Joel Montalbano.

“Our agency goal is to get two U.S. commercial providers up and running as soon as we can.”

Boeing had hoped to conduct this test flight before the end of the year, but a few glitches experienced in the uncrewed May flight led to necessary adjustments to the vessel.

An issue was detected in the propulsion system: two thrusters responsible for placing Starliner in a stable orbit failed, though officials insisted there was plenty of redundancy built into the system to overcome the problem.

Boeing’s teams later determined that “debris-related conditions” were to blame, Nappi said, adding that the origin of said debris was still unknown.

Some filters were removed to fix a pressure problem, and flight software was updated to avoid a data overload.

Boeing and SpaceX were awarded contracts in 2014, shortly after the end of the space shuttle program, during a time when the United States was left reliant on Russian Soyuz rockets for rides to the ISS.

Elon Musk’s SpaceX filled the void first, providing space “taxi” service since a successful test mission for its Dragon capsule in 2020.
…

your ads here!

The World Health Organization (WHO) said Thursday the number of new monkeypox cases fell 20% globally last week, but new cases increased in the Americas and said there is still “intense transmission” of the disease.

At a news briefing at agency headquarters in Geneva, WHO Director-General Tedros Adhanom Ghebreyesus said there are signs the monkeypox outbreak is slowing in Europe, which he credited to a combination of effective public health measures, changes in behavior and vaccination.

But the WHO chief said the opposite is true in the Americas, particularly in Latin America, where insufficient awareness or public health measures are combining with a lack of access to vaccines to “fan the flames of the monkeypox outbreak.”

Tedros said in the early stages of the monkeypox outbreak, most reported cases were in Europe, with a smaller proportion in the Americas. He said, “That has now reversed, with less than 40% of reported cases in Europe and 60% in the Americas.”

The WHO chief said Danish drug maker Bavarian Nordic signed an agreement Wednesday with WHO affiliate the Pan-American Health Organization to support access to its vaccine in Latin America and the Caribbean.

Tedros also noted that this week, globally, the world crossed another tragic milestone, with 1 million reported COVID-19 deaths in 2022.

He said, “We can’t say we are learning to live with COVID-19 when 1 million people have died with COVID-19 this year alone, when we have all the tools necessary to prevent these deaths.”

The WHO director-general, once again, asked “all governments to strengthen their efforts to vaccinate all health workers, older people and others at the highest risk, on the way to 70% vaccine coverage for the whole population.”

Some information for this report came from Reuters and Agence France-Presse.
…

your ads here!

North Korea on Thursday said it found four new fever cases in its border region with China that may have been caused by coronavirus infections, two weeks after leader Kim Jong Un declared a widely disputed victory over COVID-19.

North Korea’s state-run Korean Central News Agency said health workers were conducting genetic tests on the samples taken from four people in Ryanggang province who exhibited fevers to confirm whether they were caused by the “malignant epidemic.” The North often uses that term, along with “malignant virus,” to describe COVID-19 and the coronavirus.

Authorities immediately locked down the areas where the fever cases emerged and plan to maintain tight restrictions and quarantines until health workers determine the cause of the illness.

KCNA said health authorities were giving extra attention to the cases because none of the four patients had a history of coronavirus infections.

The country’s emergency anti-virus headquarters dispatched “talented epidemiological, virology and test experts to the area” and is taking steps to “trace all persons … connected with the suspect cases, and persons going to and from the relevant area and keep them under strict medical observation,” KCNA said.

North Korea said there have been no confirmed COVID-19 cases in any part of the country since Aug. 10 when Kim declared victory over the virus, just three months after the country acknowledged an outbreak.

Even as he ordered preventive measures eased, Kim called for vigilance and the maintaining of tight border controls to prevent the virus from reentering the country. Ryanggang province is one of the border areas where North Korean officials for years struggled to clamp down smuggling activities with China.

An official from South Korea’s Unification Ministry, which handles inter-Korean affairs, said Seoul isn’t ruling out the possibility that the virus could reemerge in the North.

“North Korea may additionally report on the situation, including whether the fevers were confirmed as COVID-19, and we would need to wait for that before making judgments,” said the official, who spoke on condition of anonymity during a background briefing.

While Kim claimed that the country’s success against the virus would be recognized as a global health miracle, experts believe the North has manipulated disclosures on its outbreak to help him maintain absolute control. The victory statement signals Kim’s aim to move to other priorities, including a possible nuclear test, experts say.

After admitting to an omicron outbreak of the virus in May, North Korea reported about 4.8 million “fever cases” across its mostly unvaccinated population of 26 million but only identified a fraction of them as COVID-19. It claimed just 74 people have died, which experts see as an abnormally small number considering the country’s lack of public health tools.

Kim’s declaration of victory over COVID-19 during a national meeting in Pyongyang was followed by a combative speech from his powerful sister, who said Kim had suffered a fever himself while steering the anti-virus campaign and laid dubious blame against South Korea while vowing deadly retaliation.

North Korea claims that its initial infections were caused by anti-Pyongyang propaganda leaflets and other items carried across the border by balloons launched by South Korean activists, a claim the South has described as “ridiculous” and unscientific.

Outside experts believe it’s more likely that the virus spread when the North briefly reopened its border with China to freight traffic in January and surged further following a military parade and other large-scale events in its capital, Pyongyang, in April.

There are concerns that the threats by Kim’s sister portend a provocation, possibly a nuclear or missile test or even border skirmishes.

Some experts say the North may try to stir up tensions as South Korea and the United States hold their biggest combined military training in years to counter the growing North Korean nuclear threat. The Ulchi Freedom Shield exercise, which involves aircraft, tanks and warships, continues in South Korea through Sept. 1.

Diplomacy between Washington and Pyongyang to defuse the nuclear standoff has stalled since 2019 over disagreements in exchanging crippling U.S.-led sanctions against the North for the North’s denuclearization steps.
…

your ads here!

A federal judge on Wednesday blocked Idaho from enforcing an abortion ban when women with pregnancy complications require emergency care, a day after a judge in Texas ruled against President Joe Biden’s administration on the same issue. 

The conflicting rulings came in two of the first lawsuits over the Democratic administration’s attempts to ease abortion access after the conservative majority U.S. Supreme Court in June overturned the 1973 Roe v. Wade decision that legalized the procedure nationwide. 

Legal experts said the two state rulings, if upheld on appeal, could force the Supreme Court to wade back into the debate. 

About half of all U.S. states have or are expected to seek to ban or curtail abortions following Roe’s reversal. Those states include Idaho and Texas, which like 11 others adopted “trigger” laws banning abortion upon such a decision. 

Abortion is already illegal in Texas under a separate, nearly century-old abortion ban that recently took effect after the U.S. Supreme Court’s decision. Idaho’s trigger ban takes effect on Thursday, the same day as those in Texas and Tennessee. 

In Idaho, U.S. District Judge B. Lynn Winmill agreed with the U.S. Justice Department that the abortion ban taking effect Thursday conflicts with a federal law that ensures patients can receive emergency “stabilizing care” at hospitals. 

Threat to patients cited

Winmill, an appointee of former Democratic President Bill Clinton, issued a preliminary injunction blocking Idaho from enforcing its ban to the extent it conflicts with federal law, citing the threat to patients. 

“One cannot imagine the anxiety and fear she will experience if her doctors feel hobbled by an Idaho law that does not allow them to provide the medical care necessary to preserve her health and life,” Winmill wrote. “From that vantage point, the public interest clearly favors the issuance of a preliminary injunction.” 

The Justice Department has said the federal Emergency Medical Treatment and Labor Act requires abortion care in emergency situations. 

Winmill’s decision came after a late-night Tuesday ruling in Texas by U.S. District Judge James Wesley Hendrix holding the U.S. Department of Health and Human Services under Biden went too far by issuing guidance holding the same federal law guaranteed abortion care. 

Hendrix agreed with Texas Attorney General Ken Paxton, a Republican, that the guidance issued in July “discards the requirement to consider the welfare of unborn children when determining how to stabilize a pregnant woman.” 

Hendrix, an appointee of former Republican President Donald Trump, said the federal statute was silent as to what a doctor should do when there is a conflict between the health of the mother and the unborn child and that Texas’s law “fills that void.” 

He issued an injunction barring the federal government from enforcing HHS’s guidance in Texas and against two groups of anti-abortion doctors who also challenged it, saying the Idaho case showed a risk the Biden administration might try to enforce it. 

Hendrix declined, though, to issue a nationwide injunction as Paxton wanted, saying the “circumstances counsel in favor of a tailored, specific injunction.” 

Appellate courts

Appeals are expected in both cases and would be heard by separate appeals courts, one based in San Francisco with a reputation for leaning liberal and another in New Orleans known for conservative rulings. 

Greer Donley, an assistant professor at the University of Pittsburgh Law School and expert on abortion law, said should those appeals courts uphold this week’s dueling rulings, the U.S. Supreme Court may feel pressured to intervene and clarify the law. 

“Without a federal right to abortion, this is the type of legal chaos that most people were predicting would be happening,” she said. 

Shannon Selden, a lawyer at Debevoise & Plimpton who represents several medical associations supporting the Justice Department’s Idaho case, said “there’s a huge cloud over physicians’ ability to provide stabilizing care for patients who need it.” 

“The Justice Department is trying lift that cloud through its Idaho action, and the Texas court has made that cloud darker,” she said.
…

your ads here!

Nigeria this week added a rotavirus vaccine to its national program that is expected to prevent 50,000 deaths of children per year from the diarrheal disease. But the launch comes amid shortages of the vaccine in countries such as Cameroon, Kenya, Senegal and Tanzania.

The launch Monday coincided with the commemoration of Africa Vaccination Week.

Officials from the World Health Organization, the United Nations children’s agency, as well as Nigeria’s Health Ministry, attended the launch in the capital.

During the event, many young children received the vaccine for free, while authorities urged citizens to embrace the measure.

“They’ll get the opportunity of taking it when they’re taking other vaccines,” said Faisal Shuaib, executive director of the National Primary Health Care Development Agency. “We need to seize this opportunity — mothers, caregivers — so that our children will be protected from this virus.”

Rotavirus is the most common cause of diarrheal disease in children under 5 years old. WHO says that globally, up to 200,000 children die each year from the disease.

Authorities say the oral vaccine could prevent up to a third of severe diarrhea cases in Nigeria.

WHO country representative Walter Kazadi Mulombo also attended the launch.

“The introduction of the rotavirus vaccine provides the opportunity to reduce the number of children dying every day from diarrheal disease caused by rotavirus,” he said.

But this month, pharmaceutical giant GlaxoSmithKline said manufacturing challenges had led to a shortfall of 4 million doses of the rotavirus this year, as well as delays in delivery.

According to GAVI-the Vaccine Alliance, the company already said it would reduce deliveries of the rotavirus vaccine by 10 million a year between 2022 and 2028.

Moses Njoku, a research fellow at Nigeria’s National Institute for Pharmaceutical Research and Development, said a shortfall should not be a challenge to Nigeria.

“The issue of them thinning out shouldn’t be a threat to a country like Nigeria if we use our internal potential,” Njoku said. “Nigeria is beginning to see the need to start indigenous efforts to start research and production, development of vaccines, as well as production of known vaccines.”

Njoku also said authorities must take delivery of the rotavirus vaccines in batches to avoid waste.

“If care is not taken, they will not be imported at the right time,” he said, adding that some might ship with little time left before an expiration date. “So, eventually you won’t even use up to 10,000 doses and you have paid the money. The supply chain management system is also very poor.”

For now, authorities will be trying to get as many children vaccinated as possible.
…

your ads here!

A group of HIV-positive people has been protesting for more than a month at the central office of India’s National AIDS Control Organization, or NACO, in New Delhi, demanding a regular supply of life-saving antiretroviral therapy — also known as ART — drugs across the country.

NACO is the nodal organization of the government of India that manages programs for the prevention and control of HIV and AIDS in the country. ART drugs work by stopping the virus from replicating in HIV-infected people, helping them live longer and reducing or stopping the infection of the virus to others.

Centers that supply ART drugs across India have been out of stock on several antiretroviral drugs for months, threatening the lives and well-being of hundreds of thousands of HIV patients, according to leaders of the group that has been protesting in Delhi since July 21.

“I have been getting distress calls from hundreds of HIV-infected persons from different states of the country reporting the shortage in supply of the ART drugs from the ART centers across the country,” Hari Shankar, a leader of the ongoing Delhi protest, told VOA.

“The crisis has been acute since April. Most of them cannot afford to buy the drugs from the market privately,” Shankar added. “We will not withdraw from this protest until they, all across the country, start receiving the ART drugs supply regularly.”

According to a government estimate, India has 2.3 million people living with HIV. In 2004, the government began providing free ART to the people living with HIV in the country. Now around 1.5 million HIV patients are dependent on the ART provided by the government.

NACO procures ART drugs and distributes them through more than 675 ART centers spread across the country. People undergoing ART visit the centers every one, two or three months to collect their drugs. But since April, the supply of the drugs has been irregular in many parts of the country, many people said.

“Earlier, we regularly used to get the stock of the drugs for one to three months. Now we get the drugs just for one week or 10 days. The ART centers even in some big hospitals in New Delhi are turning us away because of the shortage of the drugs,” said Shankar, a member of the Delhi Network of Positive People or DNP Plus, which works to facilitate better medical treatment for people living with HIV/AIDS in New Delhi.

The Delhi protest demanding a regular supply of ART drugs across the country is organized by DNP Plus.

Nisha Jha, another DNP Plus member, said that many people across the country are reporting a shortage of Dolutegravir (DTG) 50 mg, a key ART drug, from the ART centers.

“Those HIV patients who have been on the first line, second line, or third line ART for years, and are also infected with tuberculosis, need to take DTG 50 separately,” Jha told VOA.

“Because of the crisis of DTG, lives of thousands of our PLHIV brothers and sisters are in jeopardy now.”

There is a crisis of drugs like Nevirapine, Ritonavir, Lopinavir, Abacavir, and Zidovudine — which are used in different ART regimens for HIV ­patients — at ART centers across the country, Jha added.

The ART centers are asking patients to change their drug regimens because of the shortages of some drugs, many people said.

Surmick Waribam, a leader of HIV patients group Manipur Network of Positive People, or MNP Plus, in the northeastern state of Manipur, said the normal protocol calls for HIV patients to undergo certain medical tests before their ART regimens are changed.

“The ART centers are asking HIV patients to change the regimens without conducting any such medical tests. The patients are scared to change the regimen, fearing adverse impacts on their health. Being very poor, most of them cannot afford to buy the drugs from the market. So, they are left with no option but to change the regimen,” Waribam told VOA.

In response to a query from VOA, Dr. Manisha Verma, a spokesperson for the Indian health ministry, said in an emailed statement that there is “adequate stock for around 95% [of HIV patients] in India.”

“There is no stock-out of drugs and there are no instances of disruptions or non-availability of treatment services or ARV medicines at the national and state levels,” Verma said.

Dr. Mothi SN, an HIV and AIDS specialist, said that since the global roll-out of ARV medicines began in 2004, the HIV/AIDS scenario changed from being a “rapidly progressing fatal illness” to that of “a chronic manageable illness like diabetes or hypertension with a near-normal life expectancy.”

“Regular intake of ARV medicines and prompt adherence to treatment are resulting in added years of life. People with HIV may survive the infection and finally die of other age-related diseases like stroke, heart disease, cancer, etc.,” Mysore-based Mothi told VOA.

“To achieve the optimum outcome, prompt adherence to uninterrupted ARV therapy becomes the cornerstone of management of people living with AIDS.”

Waribam from Manipur said the shortage in supply of his regular ARV drugs forced him to switch to a new regimen of drugs.

“For my ARV drugs, I am dependent solely on the ART center. So, in June, like most of around 14,000 [people living with HIV] in Manipur, I agreed to switch to the new drugs the ART center offered. Even then, the ART centers are giving us drugs for three, five or 10 days,” Waribam said.

“Like thousands of others, I am also anxious and in doubt, if the new drugs would succeed to keep my viral load under check and not cause any damage to my health. …The authorities are playing with the lives of the PLHIV.”
…

your ads here!

An Ebola vaccination campaign will start in the Congolose city of Beni on Thursday after a new case of the virus was confirmed this week, the World Health Organization said on Wednesday.

More than 200 vaccine doses have been arrived in Beni, in the east of Democratic Republic of Congo, it said.

The latest confirmed case has been genetically linked to a 2018-2020 outbreak in North Kivu and Ituri provinces, which claimed nearly 2,300 lives.

Six people were killed in another flare-up from that same outbreak last year.

A WHO spokesman told Reuters the shots were provided by the organization and that inoculations would start on Thursday.

Congo’s dense tropical forests are a natural reservoir for the Ebola virus, which causes fever, body aches, and diarrhea, and can linger in the body of survivors only to resurface years later.

The vast central African country has recorded 14 outbreaks since 1976. The 2018-2020 outbreak in the east was Congo’s largest and the second largest ever recorded, with nearly 3,500 total cases.

Congo’s most recent outbreak was in northwest Equateur province. Itwas declared over in July after five deaths.
…

your ads here!

Scorching temperatures across the globe this year have people wondering if climate change is making some places too hot to live in.
…

your ads here!

Switzerland’s 1,400 glaciers have lost more than half their total volume since the early 1930s, a new study has found, and researchers say the ice retreat is accelerating at a time of growing concerns about climate change.

ETH Zurich, a respected federal polytechnic university, and the Swiss Federal Institute on Forest, Snow and Landscape Research on Monday announced the findings from a first-ever reconstruction of ice loss in Switzerland in the 20th century, based in part on an analysis of changes to the topography of glaciers since 1931.

The researchers estimated that ice volumes on the glaciers had shrunk by half over the subsequent 85 years — until 2016. Since then, the glaciers have lost an additional 12%, over just six years.

“Glacier retreat is accelerating. Closely observing this phenomenon and quantifying its historical dimensions is important because it allows us to infer the glaciers’ responses to a changing climate,” said Daniel Farinotti, a co-author of the study, which was published in scientific journal The Cryosphere.

By area, Switzerland’s glaciers amount to about half of all the total glaciers in the European Alps.

The teams drew on a combination of long-term observations of glaciers. That included measurements in the field and aerial and mountaintop photographs — including 22,000 taken from peaks between the two world wars. By using multiple sources, the researchers could fill in gaps. Only a few of Switzerland’s glaciers have been studied regularly over the years.

The research involved using decades-old techniques to allow for comparisons of the shape and position of images of terrain, and the use of cameras and instruments to measure angles of land areas. The teams compared surface topography of glaciers at different moments, allowing for calculations about the evolution in ice volumes.

Not all Swiss glaciers have been losing ice at the same rates, the researchers said. Altitude, amounts of debris on the glaciers, and the flatness of a glacier’s “snout” — its lowest part, which is the most vulnerable to melting — all affect the speeds of ice retreat.

The researchers also found that two periods — in the 1920s and the 1980s — actually experienced sporadic growth in glacier mass, but that was overshadowed by the broader trend of decline.

The findings could have broad implications for Switzerland’s long-term energy sources, since hydropower produces nearly 60% of the country’s electricity, according to government data.
…

your ads here!

British health authorities will begin offering eligible people just a fraction of the normal monkeypox vaccine dose to stretch supplies by about five times, in line with similar decisions to extend available doses in Europe and the U.S.

In a statement Monday, Britain’s Health Security Agency said patients at clinics in Manchester and London would soon get just one fifth the regular monkeypox vaccine dose as part of ongoing research, citing earlier work suggesting the smaller dose provided as effective an immune response as a full dose.

Last week, the European Medicines Agency authorized the move for its 27 members across the continent, echoing the decision made by U.S. regulators earlier this month.

“Adopting this tried and tested technique will help to maximize the reach of our remaining stock,” said Dr. Mary Ramsay, head of immunization at Britain’s Health Security Agency. She said the lowered doses would enable health workers to vaccinate “many more thousands of people.”

Last week, British officials said there were early signs the monkeypox outbreak is slowing and that case numbers are declining. Nearly 3,200 cases have been reported in the U.K. since May, with 99% of infections among men who are gay, bisexual or have sex with other men. About 70% of cases are in London.

As of last week, U.K. authorities said more than 35,000 vaccines had been administered primarily to men who have sex with men, their close contacts, and health workers.

Globally, the supply of monkeypox vaccines is extremely limited. There is only one supplier — Denmark’s Bavarian Nordic —and most doses have already been bought by the U.S., Canada, Europe and other rich countries.

Bavarian Nordic estimated its production capacity for this year was about 30 million doses. No monkeypox vaccines have so far been allotted to Africa, which has reported more than 70 suspected deaths, the highest number anywhere.

To date, more than 41,000 cases of monkeypox have appeared worldwide in 94 countries. The World Health Organization and other health agencies do not recommend mass vaccination, but have advised countries to improve their monkeypox surveillance, testing and encouraged other measures to slow the disease’s spread.

WHO has recommended that men at high risk of the disease temporarily consider reducing their number of sex partners or refrain from group or anonymous sex.
…

your ads here!

For years, global health officials have used billions of drops of an oral vaccine in a remarkably effective campaign aimed at wiping out polio in its last remaining strongholds — typically, poor, politically unstable corners of the world.

Now, in a surprising twist in the decades-long effort to eradicate the virus, authorities in London, New York and elsewhere have discovered evidence that polio is spreading there.

The original source of the virus? The oral vaccine itself.

Scientists have long known about this extremely rare phenomenon. That is why some countries have switched to other polio vaccines. But these incidental infections from the oral formula are becoming more glaring as the world inches closer to eradication of the disease and the number of polio cases caused by the wild, or naturally circulating, virus plummets.

Since 2017, there have been 396 cases of polio caused by the wild virus, versus more than 2,600 linked to the oral vaccine, according to figures from the World Health Organization and its partners.

“We are basically replacing the wild virus with the virus in the vaccine, which is now leading to new outbreaks,” said Scott Barrett, a Columbia University professor who has studied polio eradication. “I would assume that countries like the U.K. and the U.S. will be able to stop transmission quite quickly, but we also thought that about monkeypox.”

The latest incidents represent the first time in several years that vaccine-connected polio virus has turned up in rich countries.

Earlier this year, officials in Israel detected polio in an unvaccinated 3-year-old, who suffered paralysis. Several other children, nearly all of them unvaccinated, were found to have the virus but no symptoms.

In June, British authorities reported finding evidence in sewage that the virus was spreading, though no infections in people were identified. Last week, the government said all children in London ages 1 to 9 would be offered a booster shot.

In the U.S., an unvaccinated young adult suffered paralysis in his legs after being infected with polio, New York officials revealed last month. The virus has also shown up in New York sewers, suggesting it is spreading. Officials, however, said they are not planning a booster campaign because they believe the state’s high vaccination rate should offer enough protection.

Genetic analyses showed that the viruses in the three countries were all “vaccine-derived,” meaning that they were mutated versions of a virus that originated in the oral vaccine.

The oral vaccine at issue has been used since 1988 because it is cheap, easy to administer — two drops are put directly into children’s mouths — and better at protecting entire populations where polio is spreading. It contains a weakened form of the live virus.

But it can also cause polio in about two to four children per 2 million doses. (Four doses are required to be fully immunized.) In extremely rare cases, the weakened virus can also sometimes mutate into a more dangerous form and spark outbreaks, especially in places with poor sanitation and low vaccination levels.

These outbreaks typically begin when people who are vaccinated shed live virus from the vaccine in their feces. From there, the virus can spread within the community and, over time, turn into a form that can paralyze people and start new epidemics.

Many countries that eliminated polio switched to injectable vaccines containing a killed virus decades ago to avoid such risks; the Nordic countries and the Netherlands never used the oral vaccine. The ultimate goal is to move the entire world to the shots once wild polio is eradicated, but some scientists argue that the switch should happen sooner.

“We probably could never have gotten on top of polio in the developing world without the (oral polio vaccine), but this is the price we’re now paying,” said Dr. Paul Offit, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia. “The only way we are going to eliminate polio is to eliminate the use of the oral vaccine.”

Aidan O’Leary, director of WHO’s polio department, described the discovery of polio spreading in London and New York as “a major surprise,” saying that officials have been focused on eradicating the disease in Afghanistan and Pakistan, where health workers have been killed for immunizing children and where conflict has made access to some areas impossible.

Still, O’Leary said he is confident Israel, Britain and the U.S. will shut down their newly identified outbreaks quickly.

The oral vaccine is credited with dramatically reducing the number of children paralyzed by polio. When the global eradication effort began in 1988, there were about 350,000 cases of wild polio a year. So far this year, there have been 19 cases of wild polio, all in Afghanistan, Mozambique and Pakistan.

In 2020, the number of polio cases linked to the vaccine hit a peak of more than 1,100 spread out across dozens of countries. It has since declined to around 200 this year so far.

Last year, WHO and partners also began using a newer oral polio vaccine, which contains a live but weakened virus that scientists believe is less likely to mutate into a dangerous form, but supplies are limited.

To stop polio in Britain, Israel and the U.S., what is needed is more vaccination, experts say. That is something Columbia University’s Barrett worries could be challenging in the COVID-19 era.

“What’s different now is a reduction in trust of authorities and the political polarization in countries like the U.S. and the U.K.,” Barrett said. “The presumption that we can quickly get vaccination numbers up quickly may be more challenging now.”

Oyewale Tomori, a virologist who helped direct Nigeria’s effort to eliminate polio, said that in the past, he and colleagues balked at describing outbreaks as “vaccine-derived,” wary it would make people fearful of the vaccine.

“All we can do is explain how the vaccine works and hope that people understand that immunization is the best protection, but it’s complicated,” Tomori said. “In hindsight, maybe it would have been better not to use this vaccine, but at that time, nobody knew it would turn out like this.”
…

your ads here!

Echoing down the corridors of eastern Ukraine’s Pokrovsk Perinatal Hospital are the loud cries of tiny Veronika.

Born nearly two months prematurely weighing 1.5 kilograms (3 pounds, 4 ounces), the infant receives oxygen through a nasal tube to help her breathe while ultraviolet lamps inside an incubator treat her jaundice.

Dr. Tetiana Myroshnychenko carefully connects the tubes that allow Veronika to feed on her mother’s stored breast milk and ease her hunger.

Before Russia’s invasion of Ukraine in late February, three hospitals in government-controlled areas of the country’s war-torn Donetsk region had facilities to care for premature babies. One was hit by a Russian airstrike and the other had to close as a result of the fighting  — leaving only the maternity hospital in the coal mining town of Pokrovsk still operating.

Myroshnychenko, the site’s only remaining neonatologist, now lives at the hospital. Her 3-year-old son divides the week between staying at the facility and with his father, a coal miner, at home.

The doctor explains why it’s now impossible to leave: Even when the air-raid sirens sound, the babies in the hospital’s above-ground incubation ward cannot be disconnected from their lifesaving machines.

“If I carry Veronika to the shelter, that would take five minutes. But for her, those five minutes could be critical,” Myroshnychenko says.

Hospital officials say the proportion of births occurring prematurely or with complications has roughly doubled this year compared to previous times, blaming stress and rapidly worsening living standards for taking a toll on the pregnant women still left in the area.

Russia and Moscow-backed separatists now occupy just over half the Donetsk region, which is similar in size to Sicily or Massachusetts. Pokrovsk is still in a Ukrainian government-controlled area 60 kilometers (40 miles) west of the front lines.

Inside the hospital’s maternity wards, talk of the war is discouraged.

“Everything that happens outside this building of course concerns us, but we don’t talk about it,” Myroshnychenko said. “Their main concern right now is the baby.”

Although fighting in the Dontesk region started back in 2014, when Russia-backed separatists began battling the government and taking over parts of the region, new mothers are only now being kept in the hospital for longer periods because there’s little opportunity for them to receive care once they have been discharged.

Among them is 23-year-old Inna Kyslychenko, from Pokrovsk. Rocking her 2-day-old daughter Yesenia, she was considering joining the region’s massive evacuation westward to safer areas in Ukraine when she leaves the hospital. Many essential services in government-held areas of Donetsk — heat, electricity, water supplies — have been damaged by Russian bombardment, leaving living conditions that are only expected to worsen as the winter grows near.

“I fear for the little lives, not only for ours, but for all the children, for all of Ukraine,” Kyslychenko said.

More than 12 million people in Ukraine have fled their homes due to the war, according to U.N. relief agencies. About half have been displaced within Ukraine and the rest have moved to other European countries.

Moving the maternity hospital out of Pokrovsk, however, is not an option.

“If the hospital was relocated, the patients would still have to remain here,” said chief physician Dr. Ivan Tsyganok, who kept working even when the town was being hit by Russian rocket fire.

“Delivering babies is not something that can be stopped or rescheduled,” he noted.

The nearest existing maternity facility is in Ukraine’s neighboring Dnipropetrovsk region, a 3 1/2 hour drive along secondary roads, a journey considered too risky for women in late-term pregnancy.

Last week, 24-year-old Andrii Dobrelia and his wife Maryna, 27, reached the hospital from a nearby village. Looking anxious, they talked little as doctors carried out a series of tests and then led Maryna to the operating room for a C-section. Tsyganok and his colleagues hurriedly changed their clothes and prepared for the procedure.

Twenty minutes later, the cries of a newborn baby boy, Timur, could be heard. After an examination, Timur was taken to meet his father in an adjoining room.

Almost afraid to breathe, Andrii Dobrelia tenderly kissed Timur’s head and whispered to him. As the newborn calmed down on his father’s chest, tears came to Andrii’s eyes.

As the war reaches the six-month mark, Tsyganok and his colleagues says they have a more hopeful reason to stay.

“These children we are bringing into the world will be the future of Ukraine,” says Tsyganok. “I think their lives will be different to ours. They will live outside war.”
…

your ads here!

While vacationers might enjoy the Mediterranean Sea’s summer warmth, climate scientists are warning of dire consequences for its marine life as it burns up in a series of severe heat waves.

From Barcelona to Tel Aviv, scientists say they are witnessing exceptional temperature hikes ranging from 3 degrees Celsius (5.4 Fahrenheit) to 5 degrees Celsius (9 Fahrenheit) above the norm for this time of year. Water temperatures have regularly exceeded 30 C (86 F) on some days.

Extreme heat in Europe and other countries around the Mediterranean has grabbed headlines this summer, but the rising sea temperature is largely out of sight and out of mind.

Marine heat waves are caused by ocean currents building up areas of warm water. Weather systems and heat in the atmosphere can also pile on degrees to the water’s temperature. And just like their on-land counterparts, marine heat waves are longer, more frequent and more intense because of human-induced climate change.

The situation is “very worrying,” says Joaquim Garrabou, a researcher at the Institute of Marine Sciences in Barcelona. “We are pushing the system too far. We have to take action on the climate issues as soon as possible.”

Garrabou is part of a team that recently published the report on heat waves in the Mediterranean Sea between 2015 and 2019. The report says these phenomena have led to “massive mortality” of marine species.

About 50 species, including corals, sponges and seaweed, were affected along thousands of kilometers of Mediterranean coasts, according to the study, which was published in the Global Change Biology journal.

The situation in the eastern Mediterranean basin is particularly dire.

The waters off Israel, Cyprus, Lebanon and Syria are “the hottest hot spot in the Mediterranean, for sure,” said Gil Rilov, a marine biologist at Israel’s Oceanographic and Limnological Research institute, and one of the paper’s co-authors. Average sea temperatures in the summer are now consistently over 31 C (88 F).

These warming seas are driving many native species to the brink, “because every summer their optimum temperature is being exceeded,” he said.

What he and his colleagues are witnessing in terms of biodiversity loss is what is projected to happen further west in the Mediterranean toward Greece, Italy and Spain in the coming years.

Garrabou points out that seas have been serving the planet by absorbing 90% of the earth’s excess heat and 30% of carbon dioxide emitted into the atmosphere by coal, oil and gas production. This carbon-sink effect shields the planet from even harsher climate effects.

This was possible because oceans and seas were in a healthy condition, Garrabou said.

“But now we have driven the ocean to an unhealthy and dysfunctional state,” he said.

While the earth’s greenhouse gas emissions will have to be drastically reduced if sea warming is to be curtailed, ocean scientists are specifically looking for authorities to guarantee that 30% of sea areas are protected from human activities such as fishing, which would give species a chance to recover and thrive.

About 8% of the Mediterranean Sea area is currently protected.

Garrabou and Rilov said that policymakers are largely unaware of the warming Mediterranean and its impact.

“It’s our job as scientists to bring this to their attention so they can think about it,” Rilov said.

Heat waves occur when especially hot weather continues over a set number of days, with no rain or little wind. Land heat waves help cause marine heat waves and the two tend to feed each other in a vicious, warming circle.

Land heat waves have become commonplace in many countries around the Mediterranean, with dramatic side effects like wildfires, droughts, crop losses and excruciatingly high temperatures.

But marine heat waves could also have serious consequences for the countries bordering the Mediterranean and the more than 500 million people who live there if it’s not dealt with soon, scientists say. Fish stocks will be depleted and tourism will be adversely affected, as destructive storms could become more common on land.

Despite representing less than 1% of the global ocean surface area, the Mediterranean is one of the main reservoirs of marine biodiversity, containing between 4% and 18% of the world’s known marine species.

Some of the most affected species are key to maintaining the functioning and diversity of the sea’s habitats. Species like the Posidonia oceanica seagrass meadows, which can absorb vast amounts of carbon dioxide and shelters marine life, or coral reefs, which are also home to wildlife, would be at risk.

Garrabou says the mortality impacts on species were observed between the surface and 45 meters (around 150 feet) deep, where the recorded marine heat waves were exceptional. Heat waves affected more than 90% of the Mediterranean Sea’s surface.

According to the most recent scientific papers, the sea surface temperature in the Mediterranean has increased by 0.4 C (0.72 F) each decade between 1982 and 2018. On a yearly basis, it has been rising by some 0.05 C (0.09 F) over the past decade without any sign of letting up.

Even fractions of degrees can have disastrous effects on ocean health, experts say.

The affected areas have also grown since the 1980s and now covers most of the Mediterranean, the study suggests.

“The question is not about the survival of nature, because biodiversity will find way to a survive on the planet,” Garrabou said. “The question is if we keep going in this direction maybe our society, humans, will not have a place to live.”

 
…

your ads here!